Variable effects of omaveloxolone (RTA408) on primary fibroblasts with mitochondrial defects

Omaveloxolone (RTA408) is a second-generation oleanane triterpenoid Nrf2 inducer with antioxidant and anti-inflammatory properties and was reported to improve mitochondrial bioenergetics. It is currently being tested in medical trials for Friedrich ataxia, a genetic, multi-organ disease involving mi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zighan, Madleen, Arkadir, David, Douiev, Liza, Keller, Guy, Miller, Chaya, Saada, Ann
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Molecular Biosciences
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411646/
https://www.ncbi.nlm.nih.gov/pubmed/36032663
http://dx.doi.org/10.3389/fmolb.2022.890653

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9411646/
https://www.ncbi.nlm.nih.gov/pubmed/36032663
http://dx.doi.org/10.3389/fmolb.2022.890653

Ejemplares similares